Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood-derived mesenchymal stem cells for steroid-refractory graft-versus-host disease
KCT0000389Phase 2Recruiting
- Sponsor
- MEDIPOST
- Start
- Jan 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Promostem in Acute Graft-Versus-Host Disease (aGvHD) and graft-versus-host disease (GVHD), sponsored by MEDIPOST. Started Jan 2012; status: recruiting.
02
Drugs
Promostem
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on KCT0000389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000389.